1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

DGX
Quest Diagnostics IncorporatedUS flagNew York Stock Exchange
193.16
USD
+0.96
- -
21.38BMarket Cap

Total Valuation

Quest Diagnostics Incorporated carries a market capitalization of 21.38B, placing it among publicly traded companies globally. Its enterprise value stands at 28.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap21.38B
Enterprise Value28.19B

Share Statistics

Quest Diagnostics Incorporated currently has 111.00M shares outstanding.

Shares Outstanding111.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Quest Diagnostics Incorporated trades at a trailing price-to-earnings ratio of 21.29. The price-to-sales ratio is 1.93, and the price-to-book ratio stands at 2.15.

PE Ratio21.29
PS Ratio1.93
PB Ratio2.15
P/TBV Ratio-7.05
P/FCF Ratio11.92
P/OCF Ratio11.79

Enterprise Valuation

On an enterprise value basis, Quest Diagnostics Incorporated trades at an EV/EBITDA multiple of 12.87 and an EV/FCF ratio of 13.72. The EV/Sales ratio of 2.50 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.47 provides insight into valuation relative to core operating earnings.

EV / Sales2.50
EV / EBITDA12.87
EV / EBIT17.47
EV / FCF13.72

Financial Position

Quest Diagnostics Incorporated maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.71, indicating elevated leverage, while an interest coverage ratio of 8.11 demonstrates adequate ability to service its debt obligations.

Current Ratio1.18
Quick Ratio0.91
Debt / Equity82.71
Debt / EBITDA2.92
Interest Coverage8.11

Financial Efficiency

Quest Diagnostics Incorporated posts a return on equity of 10.43 and a return on invested capital of 8.86.

Return on Equity (ROE)10.43
Return on Assets (ROA)6.31
Return on Invested Capital (ROIC)8.86
Return on Capital Employed (ROCE)7.12
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover36.40

Taxes

Over the trailing twelve months, Quest Diagnostics Incorporated has paid 329.00M in income taxes, reflecting an effective tax rate of 23.91.

Income Tax329.00M
Effective Tax Rate23.91

Stock Price Statistics

Quest Diagnostics Incorporated's stock has gained approximately 11.27369% over the past 52 weeks. The 50-day moving average sits at 194.20, while the 200-day moving average is 188.43.

Beta (5Y)N/A
52-Week Price Change11.27369%
50-Day Moving Average194.20
200-Day Moving Average188.43
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Quest Diagnostics Incorporated generated 11.28B in revenue and converted that into 1.02B in net income, yielding earnings per share of 9.56. EBITDA reached 2.19B, while operating income came in at 1.61B.

Revenue11.28B
Gross Profit3.74B
Operating Income1.61B
Pretax Income1.38B
Net Income1.02B
EBITDA2.19B
EBIT1.61B
Earnings Per Share (EPS)9.56

Balance Sheet

Quest Diagnostics Incorporated holds 393.00M in cash and equivalents against 6.41B in total debt, resulting in a net debt position of 5.27B. Total book value stands at 10.15B, with working capital of 389.00M providing operational flexibility.

Cash & Cash Equivalents393.00M
Total Debt6.41B
Net Debt5.27B
Equity (Book Value)10.15B
Book Value Per Share91.26
Working Capital389.00M

Cash Flow

Quest Diagnostics Incorporated produced 1.85B in operating cash flow over the past twelve months.

Operating Cash Flow1.85B
Capital ExpendituresN/A
Free Cash Flow1.85B
FCF Per Share16.63

Margins

Quest Diagnostics Incorporated operates with a gross margin of 33.20, reflecting its pricing power and cost economics. The operating margin of 14.31 and net profit margin of 9.08 provide insight into operational efficiency.

Gross Margin33.20
Operating Margin14.31
Pretax Margin12.20
Profit Margin9.08
EBITDA Margin19.43

Dividends & Yields

The company's payout ratio of 31.71 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share3.21
Dividend YieldN/A
Payout Ratio31.71
Shareholder Yield4.49
FCF Yield8.39

Stock Splits

Quest Diagnostics Incorporated's most recent stock split took place on June 21, 2005 with a 1:2 split ratio.

Last Split Date6/21/2005
Split Ratio1:2

Scores

Quest Diagnostics Incorporated posts an Altman Z-Score of 6.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.83